Raldesy is a drug owned by Kamat Pharmatech Llc. It is protected by 1 US drug patent filed in 2024 out of which none have expired yet. Based on its patents and exclusivities, its generic launch date is estimated to be Mar 13, 2029. Details of Raldesy's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents protect the active ingredient(API) of the drug. Only drug patent owner can launch products that use this active ingredient until these patents expire. | |||
| US8133893 | Trazodone and trazodone hydrochloride in purified form |
Mar, 2029
(4 years from now) | Active |
US patents provide insights into the exclusivity only within the United States, but Raldesy is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Raldesy's family patents as well as insights into ongoing legal events on those patents.
Raldesy's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Raldesy's generic launch date based on the expiry of its last outstanding patent is estimated to be Mar 13, 2029 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Raldesy Generic API suppliers:
Trazodone Hydrochloride is the generic name for the brand Raldesy. 23 different companies have already filed for the generic of Raldesy, with Zydus Pharms having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Raldesy's generic
Alternative Brands for Raldesy
There are several other brand drugs using the same active ingredient (Trazodone Hydrochloride) as Raldesy. Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.
Apart from brand drugs containing the same ingredient, some generics have also been filed for Trazodone Hydrochloride, Raldesy's active ingredient. Check the complete list of approved generic manufacturers for Raldesy
About Raldesy
Raldesy is a drug owned by Kamat Pharmatech Llc. Raldesy uses Trazodone Hydrochloride as an active ingredient. Raldesy was launched by Kamat in 2024.
Approval Date:
Raldesy was approved by FDA for market use on 26 November, 2024.
Active Ingredient:
Raldesy uses Trazodone Hydrochloride as the active ingredient. Check out other Drugs and Companies using Trazodone Hydrochloride ingredient
Dosage:
Raldesy is available in solution form for oral use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 10MG/ML | SOLUTION | Prescription | ORAL |